Biovaxys Technology Corporation (QB) (BVAXF)
USOTC
Year End October 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -161k | -11k | -733k | -4.17M | -9.36M | -7.9M |
Pre Tax Income | -161k | -230k | -1.17M | -6.46M | -11.73M | -7.69M |
Net Income | -161k | -230k | -1.17M | -6.46M | -11.73M | -7.69M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.029 | -0.021 | -0.016 | -0.07 | -0.108 | -0.053 |
EBIT | -161k | -11k | -733k | -4.17M | -9.59M | -7.66M |
EBITDA | -161k | -11k | -733k | -4.17M | -1.96M | -6.45M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.